{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:21:16Z","timestamp":1793726476953,"version":"4.6.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ahj.2020.04.019","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T19:03:09Z","timestamp":1588532589000},"page":"120-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Outcomes in Kawasaki disease patients with coronary artery abnormalities at admission"],"prefix":"10.1016","volume":"225","author":[{"given":"Ryusuke","family":"Ae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Y.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan A.","family":"Maddox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence B.","family":"Schonberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosikazu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanari","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuko","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Kosami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teppei","family":"Sasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermias D.","family":"Belay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2020.04.019_bb0005","first-page":"178","article-title":"Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children","volume":"16","author":"Kawasaki","year":"1967","journal-title":"Arerugi"},{"key":"10.1016\/j.ahj.2020.04.019_bb0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1542\/peds.54.3.271","article-title":"A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan","volume":"54","author":"Kawasaki","year":"1974","journal-title":"Pediatrics"},{"key":"10.1016\/j.ahj.2020.04.019_bb0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","article-title":"Kawasaki syndrome","volume":"364","author":"Burns","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2020.04.019_bb0020","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.jacc.2015.12.073","article-title":"Kawasaki Disease","volume":"67","author":"Newburger","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2020.04.019_bb0025","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2020.04.019_bb0030","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(84)91504-6","article-title":"High-dose intravenous gammaglobulin for Kawasaki disease","volume":"2","author":"Furusho","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2020.04.019_bb0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gamma globulin","volume":"315","author":"Newburger","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2020.04.019_bb0040","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","article-title":"A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome","volume":"324","author":"Newburger","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2020.04.019_bb0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/01.inf.0000202068.30956.16","article-title":"Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003","volume":"25","author":"Belay","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ahj.2020.04.019_bb0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2188\/jea.JE20140089","article-title":"Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey","volume":"25","author":"Makino","year":"2015","journal-title":"J Epidemiol"},{"key":"10.1016\/j.ahj.2020.04.019_bb0055","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/ped.13544","article-title":"Epidemiological observations of Kawasaki disease in Japan, 2013-2014","volume":"60","author":"Makino","year":"2018","journal-title":"Pediatr Int"},{"key":"10.1016\/j.ahj.2020.04.019_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/ped.13809","article-title":"The nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016","author":"Makino","year":"2019","journal-title":"Pediatr Int"},{"key":"10.1016\/j.ahj.2020.04.019_bb0065","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/0002-9149(82)90256-9","article-title":"Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study","volume":"49","author":"Kato","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2020.04.019_bb0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0022-3476(82)80639-2","article-title":"Regression of aneurysms in Kawasaki disease: a pathological study","volume":"100","author":"Sasaguri","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.ahj.2020.04.019_bb0075","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/01.CIR.75.2.387","article-title":"Regression of coronary aneurysms in patients with Kawasaki syndrome","volume":"75","author":"Takahashi","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2020.04.019_bb0080","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/01.CIR.94.6.1379","article-title":"Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients","volume":"94","author":"Kato","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2020.04.019_bb0085","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1161\/01.CIR.101.25.2935","article-title":"Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study","volume":"101","author":"Suzuki","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2020.04.019_bb0090","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00392-009-0032-2","article-title":"Long-term follow-up of acute changes in coronary artery diameter caused by Kawasaki disease: risk factors for development of stenotic lesions","volume":"98","author":"Mueller","year":"2009","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ahj.2020.04.019_bb0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/apc.APC_172_16","article-title":"Long-term outcome of coronary artery dilatation in Kawasaki disease","volume":"11","author":"Advani","year":"2018","journal-title":"Ann Pediatr Cardiol"},{"key":"10.1016\/j.ahj.2020.04.019_bb0100","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s10067-018-3977-6","article-title":"Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China","volume":"37","author":"Tang","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ahj.2020.04.019_bb0105","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/archdischild-2014-306427","article-title":"Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous gamma-immunoglobulin therapy","volume":"100","author":"Lin","year":"2015","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ahj.2020.04.019_bb0110","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jpeds.2018.07.090","article-title":"Kawasaki disease outcomes and response to therapy in a multiethnic community: A 10-year experience","volume":"203","author":"Skochko","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.ahj.2020.04.019_bb0115","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0022-3476(05)81894-3","article-title":"Outcome of coronary artery aneurysms after Kawasaki disease","volume":"121","author":"Akagi","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.ahj.2020.04.019_bb0120","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003289","article-title":"Coronary artery aneurysms in kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population","volume":"5","author":"Friedman","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2020.04.019_bb0125","doi-asserted-by":"crossref","unstructured":"Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J. 2014; 78: 2521\u20132562. doi.","DOI":"10.1253\/circj.CJ-66-0096"},{"key":"10.1016\/j.ahj.2020.04.019_bb0130","first-page":"546","article-title":"Ordinal logistic regression in medical research","volume":"31","author":"Bender","year":"1997","journal-title":"J R Coll Physicians Lond"},{"key":"10.1016\/j.ahj.2020.04.019_bb0135","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archpedi.160.7.686","article-title":"Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome","volume":"160","author":"Baer","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ahj.2020.04.019_bb0140","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/INF.0b013e318266bcf9","article-title":"Preventing coronary artery abnormalities: a need for earlier diagnosis and treatment of Kawasaki disease","volume":"31","author":"Dominguez","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ahj.2020.04.019_bb0145","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpeds.2017.03.025","article-title":"High risk of coronary artery aneurysms in infants younger than 6 months of age with Kawasaki disease","volume":"185","author":"Salgado","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.ahj.2020.04.019_bb0150","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0022-3476(98)70229-X","article-title":"Coronary artery dimensions may be misclassified as normal in Kawasaki disease","volume":"133","author":"de Zorzi","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.ahj.2020.04.019_bb0155","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S2352-4642(18)30334-1","article-title":"Kawasaki disease: an essential comparison of coronary artery aneurysm criteria","volume":"2","author":"Burns","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.ahj.2020.04.019_bb0160","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1253\/circj.CJ-17-0433","article-title":"Nationwide survey of patients with giant coronary aneurysm secondary to Kawasaki disease 1999-2010 in Japan","volume":"82","author":"Fukazawa","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2020.04.019_bb0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/INF.0b013e31815922b5","article-title":"Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan","volume":"27","author":"Uehara","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ahj.2020.04.019_bb0170","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12969-018-0264-7","article-title":"Kawasaki disease: abnormal initial echocardiogram is associated with resistance to IV Ig and development of coronary artery lesions","volume":"16","author":"Chbeir","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.ahj.2020.04.019_bb0175","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011319","article-title":"Risk model development and validation for prediction of coronary artery aneurysms in Kawasaki disease in a North American population","volume":"8","author":"Son","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2020.04.019_bb0180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","article-title":"Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease","volume":"149","author":"Egami","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.ahj.2020.04.019_bb0185","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease","volume":"113","author":"Kobayashi","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2020.04.019_bb0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpeds.2017.05.034","article-title":"Cardiac complications, earlier treatment, and initial disease severity in Kawasaki disease","volume":"188","author":"Abrams","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.ahj.2020.04.019_bb0195","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/ped.13512","article-title":"Effect of i.v. immunoglobulin in the first 4 days of illness in Kawasaki disease","volume":"60","author":"Shiozawa","year":"2018","journal-title":"Pediatr Int"},{"key":"10.1016\/j.ahj.2020.04.019_bb0200","doi-asserted-by":"crossref","unstructured":"Dionne A, Burns JC, Dahdah N, et al. Treatment intensification in patients with Kawasaki disease and coronary aneurysm at diagnosis. Pediatrics 2019; 143(6) doi: https:\/\/doi.org\/10.1542\/peds.2018-3341","DOI":"10.1542\/peds.2018-3341"},{"key":"10.1016\/j.ahj.2020.04.019_bb0205","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial","volume":"379","author":"Kobayashi","year":"2012","journal-title":"Lancet"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870320301277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870320301277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:04:31Z","timestamp":1757570671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870320301277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":41,"alternative-id":["S0002870320301277"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2020.04.019","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes in Kawasaki disease patients with coronary artery abnormalities at admission","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2020.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}